These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2943019)

  • 1. Molecular markers of hemostatic activation in atherosclerosis: a new concept in diagnostic profiling of endogenous pathophysiologic transition.
    Fareed J; Walenga JM; Baker WH; Hayes A; Hoppensteadt DA
    Semin Thromb Hemost; 1986 Apr; 12(2):102-9. PubMed ID: 2943019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
    Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
    Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of several laboratory tests on prethrombotic status in arterial vascular pathology].
    Arosio E; Lechi C; Pancera P
    Recenti Prog Med; 1989 Jan; 80(1):18-24. PubMed ID: 2523551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
    Walenga JM; Fareed J; Hoppensteadt D
    Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of chuan-xiong granules on platelet aggregation, plasma beta-thromboglobulin, platelet factor IV, thromboxane B2 and 6-keto-prostaglandin F1 alpha in coronary disease patients].
    Yu Z; Chen KJ
    Zhong Xi Yi Jie He Za Zhi; 1987 Jan; 7(1):8-11, 3. PubMed ID: 2954711
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinopeptide A and platelet factor levels in unstable angina pectoris.
    Théroux P; Latour JG; Léger-Gauthier C; De Lara J
    Circulation; 1987 Jan; 75(1):156-62. PubMed ID: 2947740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet aggregation, coronary artery disease progression and future coronary events.
    Lam JY; Latour JG; Lespérance J; Waters D
    Am J Cardiol; 1994 Feb; 73(5):333-8. PubMed ID: 8109546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies.
    Papp AC; Hatzakis H; Bracey A; Wu KK
    Thromb Haemost; 1989 Feb; 61(1):15-9. PubMed ID: 2526384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of 2-acetoxy-trifluoromethylbenzoic acid (Triflusal) on platelet function after repeated oral administration in man: a pharmacological clinical study.
    Messa GL; Franchi M; Auteri A; Di Perri T
    Int J Clin Pharmacol Res; 1993; 13(5):263-73. PubMed ID: 8200721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are there markers of the blood-vessel wall interaction and of thrombus formation that can be used clinically?
    Gershlick AH
    Circulation; 1990 Jan; 81(1 Suppl):I28-34; discussion I40-1. PubMed ID: 2136816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet half-life in comparison to other in-vivo platelet function parameters such as thromboxane B2, beta-thromboglobulin and platelet factor 4 in patients with atherosclerotic lesions with and without hyperlipoproteinemia.
    Strobl-Jäger E; Fitscha P; Kaliman J; Widhalm K; Sinzinger H
    Vasa; 1986; 15(4):373-8. PubMed ID: 2948337
    [No Abstract]   [Full Text] [Related]  

  • 13. The molecular markers of hemostatic activation on coronary artery disease.
    Ulutin T; Sönmez H; Uçişik N; Süer S; Bayram C; Kökoglu E; Sultuybek G
    Thromb Res; 1997 Nov; 88(3):329-32. PubMed ID: 9526953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Newly developed stenocardia: functional activity of thrombocytes].
    Shalaev SV; Panchenko EP; Masenko VP; Smirnov IE; Vinogradova IV
    Kardiologiia; 1988 Jul; 28(7):63-8. PubMed ID: 2974904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmatic markers of haemostatic system activation in patients with solid neoplasms.
    Sagripanti A; Carpi A; Ferdeghini M; Baicchi U; Grassi B
    J Nucl Med Allied Sci; 1990; 34(4):321-32. PubMed ID: 2151044
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of specific platelet activation markers with carotid arterial wall thickness.
    Ghaddar HB; Cortes J; Salomaa V; Kark JD; Davis CE; Folsom AR; Heiss G; Stinson V; Wu KK
    Thromb Haemost; 1995 Sep; 74(3):943-8. PubMed ID: 8571326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in platelet function in patients with arterial hypertension].
    Malý J; Pecka M; Pintérová E; Pidrman V; Bláha M; Siroký O; Jebavý L
    Vnitr Lek; 1995 Jul; 41(7):458-61. PubMed ID: 7571480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
    Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
    Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of hemostatic molecular markers.
    Kazama M
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1387-94. PubMed ID: 2854693
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased intravascular coagulation associated with pregnancy.
    Gerbasi FR; Bottoms S; Farag A; Mammen E
    Obstet Gynecol; 1990 Mar; 75(3 Pt 1):385-9. PubMed ID: 2137574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.